Study of the modulatory activity of BZ (ω) receptor ligands on defensive behaviors in mice: Evaluation of the importance of intrinsic efficacy and receptor subtype selectivity

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 23, Issue 1, 1999, Pages 81-98

  Griebel, Guy ^a   Perrault, Ghislaine ^a   Sanger, David J ^a  

^a SANOFI   (France)

Author keywords

Abecarnil; Anxiety; Benzodiazepines; Bretazenil, BZ ( ) receptors; Defensive behaviors; Diazepam; Intrinsic efficacy; Subtype selectivity; Swiss mice

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ABECARNIL; BENZODIAZEPINE RECEPTOR; BRETAZENIL; DIAZEPAM; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; DEFENSIVE BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; LIGAND BINDING; MOUSE; NONHUMAN;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINONES; CARBOLINES; DIAZEPAM; ESCAPE REACTION; MALE; MICE; MOTOR ACTIVITY; RATS; RECEPTORS, GABA-A;

EID: 0033013489     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00093-1     Document Type: Article

References (39)

1. Blanchard, R. J., Yudko, E. B., Rodgers, R. J. and Blanchard, D. C. (1993) Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety. Behav. Brain Res. 58: 155-165.
2. Cole, J. C. and Rodgers, R. J. (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4: 573-580.
3. Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G., Langer, S. Z. and Bartholini, G. (1986) Zolpidem, a novel non-benzodiazepine hypnotic: I. Neuropharmacological and behavioral effects. J. Pharmacol. Exp. Ther. 237: 649-658.
4. Facklam, M., Schoch, P., Bonetti, E. P., Jenck, F., Martin, J. R., Moreau, J. L. and Haefely, W. E. (1992a) Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 261: 1113-1121.
5. Facklam, M., Schoch, P. and Haefely, W. E. (1992b) Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. J. Pharmacol. Exp. Ther. 261: 1107-1112.
6. A receptor. Eur. J. Pharmacol. 246: 283-287.
7. A receptors. J. Pharmacol. Exp. Ther. 266: 1018-1028.
8. Griebel, G., Blanchard, D. C., Jung, A. and Blanchard, R. J. (1995a) A model of 'antipredator' defense in Swiss-Webster mice: Effects of benzodiazepine receptor ligands with different intrinsic activities. Behav. Pharmacol. 6: 732-745.
9. 2A antagonist pirenperone. Pharmacol. Biochem. Behav. 51: 235-244.
10. Griebel, G., Sanger, D. J. and Perrault, G. (1996a) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124: 245-254.
11. Griebel, G., Sanger, D. J. and Perrault, G. (1996b) Further evidence for differences between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharm. 35: 1081-1091.
12. Griebel, G., Sanger, D. J. and Perrault, G. (1996c) The mouse defense test battery: Evaluation of the effects of non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Behav. Pharmacol. 7: 560-572.
13. Griebel, G., Sanger, D. J. and Perrault, G. (1997) Genetic differences in the mouse defense test battery. Aggress. Behav. 23: 19-31.
14. Haefely, W., Martin, J. R. and Schoch, P. (1990) Novel anxiolytics that acts as partial agonists at benzodiazepine receptors. Trends Pharmacol. Sci. 11: 452-456.
15. Jenck, F., Moreau, J. L., Bonetti, E. P., Martin, J. R. and Haefely, W. E. (1992) Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: Neuropharmacological profile of a potential anxiolytic. J. Pharmacol. Exp. Ther. 262: 1121-1127.
16. Jones, G. H., Schneider, C., Schneider, H. H., Seidler, J., Cole, B. J. and Stephens, D. N. (1994) Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: An analysis based on fractional receptor occupancies. Psychopharmacology 114: 191-199.
17. A receptor. J. Pharmacol. Exp. Ther. 266: 385-391.
18. Langer, S. Z. and Arbilla, S. (1988) Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes. Pharmacol. Biochem. Behav. 29: 763-766.
19. Lippa, A. S., Coupet, J., Greenblatt, E. N., Klepner, C. A. and Beer, B. (1979) A synthetic non-benzodiazepine ligand for benzodiazepine receptors: A probe for investigating neuronal substrates of anxiety. Pharmacol. Biochem. Behav. 11: 99-106.
20. A benzodiazepine receptor heterogeneity: Neurophysiological implications. Neuropharm. 34: 245-254.
21. Martin, J. R., Pieri, L., Bonetti, E. P., Schaffner, R., Burkard, W. P., Cumin, R. and Haefely, W. E. (1988) Ro 16-6028: A novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry 21: 360-362.
22. Martin, J. R., Schoch, P., Jenck, F., Moreau, J.-L. and Haefely, W. E. (1993) Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero. Psychopharmacology 111: 415-422.
23. Ozawa, M., Nakada, Y., Sugimachi, K., Yabuuchi, F., Akai, T., Mizuta, E., Kuno, S. and Yamaguchi, M. (1994) Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates. Jpn. J. Pharmacol. 64: 179-187.
24. Perrault, G., Morel, E., Sanger, D. J. and Zivkovic, B. (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur. J. Pharmacol. 187: 487-494.
25. A receptor subtypes. In: Anxiolytic β-carbolines, D.N. Stephens (Ed),: 50-61, Springer-Verlag, Berlin.
26. A receptor α5-subunit creates novel type II benzodiazepine receptor pharmacology. J. Neurocnem. 54: 1802-1804.
27. Puia, G., Ducic, I., Vicini, S. and Costa, E. (1992) Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor. Proc. Natl. Acad. Sci. U. S. A. 89: 3620-3624.
28. Sanger, D. J., Benavides, J., Perrault, G., Morel, E., Cohen, C., Joly, D. and Zivkovic, B. (1994) Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes. Neurosci. Biobehav. Rev. 18: 355-372.
29. Sanger, D. J. (1995) The behavioural effects of novel benzodiazepine (ω) receptor agonists and partial agonists: Increases in punished responding and antagonism of the pentylenetetrazole cue. Behav. Pharmacol. 6: 116-126.
30. Sanger, D. J., Joly, D. and Perrault, G. (1995) Benzodiazepine (ω) receptor partial agonists and the acquisition of conditioned fear in mice. Psychopharmacology 121: 104-108.
31. A receptor subtypes. Pharmacol. Rev. 47: 181-234.
32. Sieghart, W. and Schuster, A. (1984) Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus. Pharmacol. Biochem. Behav. 33: 4033-4038.
33. Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V. and Beer, B. (1979) Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors. Pharmacol. Biochem. Behav. 10: 825-830.
34. Stephens, D. N., Schneider, H. H., Kehr, W., Andrews, J. S., Rettig, K. J., Turski, L., Schmiechen, R., Turner, J. D., Jensen, L. H. and Petersen, E. N. (1990) Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J. Pharmacol. Exp. Ther. 253: 334-343.
35. Turski, L. and Stephens, D. N. (1993) Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: A comparison with diazepam. J. Pharmacol. Exp. Ther. 267: 1215-1220.
36. Vorobjev, V. S., Sharonova, I. N., Skrebitsky, V. G., Schneider, H. H. and Stephens, D. N. (1995) Abecarnil enhances GABA-induced currents in acutely isolated cerebellar purkinje cells. Neuropharm. 34: 157-163.
37. Wafford, K. A., Whiting, P. J. and Kemp, J. A. (1993) Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acid receptor subtypes. Mol. Pharmacol. 43: 240-244.
38. Witkin, J. M., Acri, J. B., Wong, G., Gleeson, S. and Barrett, J. E. (1996) Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons. J. Pharmacol. Exp. Ther. 277: 87-96.
39. Zivkovic, B., Perrault, G. and Sanger, D. (1992) Receptor subtype-selective drugs: A new generation of anxiolytics and hypnotics. In: Target Receptors for Anxiolytics and Hypnotics: From Molecular Pharmacology to Therapeutics, J. Mendlewitz and G. Racagni (Eds),: 55-73, Karger, Basel.